Data-driven pharmaceutical intelligence for biotech investors, pharma operators, consultants, and intelligence teams.

Weekly intelligence for pharma decision-makers.

No paywall. No spam. Unsubscribe anytime.

Intelligence powered by the Humanexa engine.

Therapeutic Area

Myopia

Therapeutic area intelligence for Myopia with 2 indexed intelligence signals across regulatory, clinical, competitive, and market developments.

Companies

No related entities indexed yet.

ClinicalJuly 14, 2026

The DONUT trial will evaluate the efficacy of 0.05% atropine drops in delaying nearsightedness in children compared to placebo.

ClinicalJuly 13, 2026

A machine learning model has been developed to predict cycloplegic refraction in myopic adults using non-cycloplegic measurements.

No catalysts indexed for this entity yet.

No related entities indexed yet.

Newsletter

Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.

No paywall. No spam. Unsubscribe anytime.